HEMOGENYX PHARMACEUTICALS PLC
08401609Research and experimental development on biotechnology
HEMOGENYX PHARMACEUTICALS PLC
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
6 Heddon Street London W1B 4BT England
Full company profile for HEMOGENYX PHARMACEUTICALS PLC (08401609), an active life sciences and medical technology company based in London, England. Incorporated 13 Feb 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2014–2025)
Cash in Bank
£1.59M
Net Assets
£1.14M
Total Liabilities
£3.03M
Turnover
£7.00k
Employees
16
Debt Ratio
73%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Dec Year End | 2024 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 7 funding rounds
Sign up to view complete fundraising history
Investors (3)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 3 | Nov 2020 | IPO |
| Investor 2 | Sept 2023 | IPO |
| Investor 1 | Nov 2024 | IPO |
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Vladislav Sandler
Ceased 4 Oct 2018
Alexis Sandler
Ceased 4 Oct 2018
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 16 May 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 16 May 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 8 May 2026 | Capital | Allotment of shares (GBP 14,051,114.0903) on 27 Apr 2026 | |
| 3 Mar 2026 | Confirmation Statement | Confirmation statement made on 13 Feb 2026 with no updates | |
| 27 Feb 2026 | Capital | Allotment of shares (GBP 14,047,368.7703) on 18 Feb 2026 |
Annual accounts made up to 31 Dec 2025
Annual accounts made up to 31 Dec 2025
Allotment of shares (GBP 14,051,114.0903) on 27 Apr 2026
Confirmation statement made on 13 Feb 2026 with no updates
Allotment of shares (GBP 14,047,368.7703) on 18 Feb 2026
Recent Activity
Latest Activity
Annual accounts made up to 31 Dec 2025
1 months ago on 16 May 2026
Annual accounts made up to 31 Dec 2025
1 months ago on 16 May 2026
Allotment of shares (GBP 14,051,114.0903) on 27 Apr 2026
1 months ago on 8 May 2026
Confirmation statement made on 13 Feb 2026 with no updates
4 months ago on 3 Mar 2026
Allotment of shares (GBP 14,047,368.7703) on 18 Feb 2026
4 months ago on 27 Feb 2026